Decades of innovating medical aesthetics research Did you know?

Your conscientious biotech CRO

The first CRO in the world to achieve HRPP accreditation Benefits to your clinical study

Pioneering ethical advancements in aesthetics across the globe Explore our medical aesthetics solutions

Research with a Conscience® Discover the ethica CRO difference

Driving Ethical Excellence in Biotech Clinical Research

Decades of experience in biotech make ethica a trusted partner for projects that are complex in nature. ethica CRO provides biopharmaceutical companies integrity of data through responsiveness, accuracy, and efficiency for the well-being of all research participants.

1st CRO in the world to have achieved HRPP accreditation

Only CRO in the world to have achieved accreditation from 3 different accrediting bodies

Played a pivotal role in shaping the neurotoxin application landscape

4 out of 5 studies are focused in medical aesthetics

Integrated research participants as partners in research since 2002

Our CRO Services

Medical Aesthetics

Our expertise spans the full spectrum of aesthetic medicine, ensuring that new treatments not only meet the highest standards of quality but also address the diverse needs of patients seeking aesthetic enhancements. Our Medical Aesthetics CRO services stand at the forefront of this journey, offering a comprehensive suite of services designed to bring groundbreaking treatments from concept to reality. With a focus on safety, efficacy, and regulatory compliance, we support the development and testing of innovative solutions in:

Dermatology

In the world of dermatology, where the quest for healthier skin intersects with cutting-edge science, our Dermatology CRO services are second to none. We bring together a team of dedicated experts who understand the nuances of dermatological conditions and the complexities of clinical trials.

Our approach is simple yet effective: we focus on ethics, integrity and efficiency to drive your research forward. From early-phase explorations to pivotal trials, we offer a comprehensive suite of services designed to navigate the regulatory landscape and achieve meaningful results.

Clinical Study Management

At ethica CRO, we understand the complexities and challenges of conducting clinical trials in the biotech, aesthetics, and dermatology sectors. Our clinical study management services are designed to streamline your research process, ensuring that every phase of your trial is executed with precision and care.

From clinical trial project management to clinical monitoring and site management, our team is dedicated to the integrity of your study and the safety of its participants. Biostatistics and data management are also key components of our offerings, providing you with the statistical power to draw meaningful conclusions and the data integrity your study demands.

Trust us to bring clarity and precision to your clinical research, delivering results that stand up to scrutiny and accelerate your path to market.

Human Research Protection Program (HRPP)

ethica CRO stands out as the only contract research organization in the world to have earned HRPP accreditation from three distinct accrediting bodies. This achievement underscores our commitment to the highest standards of ethical conduct and quality in clinical research.

Our Human Research Protection Program (HRPP) plays a pivotal role in safeguarding the rights and welfare of human research participants. It ensures that all involved in the research, including investigators, sponsors, and staff, are well-educated on ethical practices and are trained to execute study procedures without conflicts of interest.

Our HRPP also includes a robust system for reporting and managing unanticipated problems, ensuring compliance with all relevant laws and regulations while prioritizing participant rights.

Our CRO Expertise

ethica CRO’s multidisciplinary team of industry leaders has extensive scientific expertise and a depth of clinical management experience to flawlessly manage your clinical development program.

Gain efficiencies in your study without compromising quality or ethical standards.

Our extensive experience designing and conducting studies using various designs in medical aesthetics, dermatology, neurology, respiratory disorders, medical devices, and Investigator Initiated Trials will save you time and effort, because we do it right, the first time.

Meet your clinical objectives within budget and experience true ethical acceleration™.

A CRO That Puts Quality First

Our Commitment to You

At ethica CRO, the research participant lies at the heart of what we do. ethica CRO is the 1st accredited Contract Research Organization in the world and an industry leader in research ethics. We take pride in delivering superior client outcomes while ensuring the welfare, safety and rights of research participants. We rely on our human research protection program, quality management system, and innovative data technology to deliver highly responsive clinical research services according to the highest standards of ethical and scientific practice.

Case Studies

Case Study: Innovative Advances in Scar Management Using an Injectable Peptide

Medical Aesthetics

This case study showcases a scar treatment project by a US-based biotechnology company, leveraging fibromodulin-based peptides. Facing the challenge of enhancing both cosmetic and functional wound outcomes, ethica CRO employed the Northwestern University Scar Model for a comprehensive assessment through a double-blind, multicenter study.

Investigator-Initiated Trials

IIT

Our team at ethica CRO managed a series of investigator-initiated trials (IITs) for aUS-based pharmaceuticals company. The main objective of these trials was to demonstrate the efficacy of botulinum toxin (BTX) for a number of off-label indications for aesthetic applications, as BTX was only approved for the treatment of glabellar lines at the time. Another purpose of these IITs was to enhance understanding of the effects and impacts of this drug, such as patient satisfaction, diffusion, duration of action, and social perception, among other factors.

Ensuring Data Consistency within a Diverse CF Population

Respiratory Disease

Hundreds of millions of people around the world suffer from respiratory diseases—asthma, cystic fibrosis (CF), and bronchiectasis being among the most prevalent conditions. CF affects 1 in every 3600 children born in Canada, making it the most common fatal genetic disease in our country. There is currently no cure for CF, but there exist treatment options that have been shown to improve the symptoms and quality of life of people living with this debilitating condition.

Meeting Unique Technical Challenges: The Case of FDA’s First Approval of a Dermal Filler for the Treatment of Acne Scars

Dermatology

Acne is the most common skin disorder in the U.S. affecting 40-50 million people. Up to 95% of people with acne may go on to suffer from scarring. Acne scarring can have significant impact on well-being and quality of life, particularly for people with moderate to severe acne scarring.